Ace the ISMPP Publication Primer 2026 – Publish Your Way to Success!

The enforcement of a Corporate Integrity Agreement (CIA) is typically triggered by an investigation under the False Claims Act. When an organization is found to have made false claims to the federal government, particularly in relation to healthcare reimbursement, this can lead to significant legal and financial scrutiny. The CIA is a mechanism put in place as part of a settlement to ensure that the organization improves its compliance practices and adheres to legal and ethical standards in the future.

Investigations under the False Claims Act often expose systemic issues that require formal remediation efforts, and the CIA serves as a tool to monitor compliance with these obligations over a specified period. This agreement usually includes provisions for enhanced internal oversight, regular reporting to the Office of Inspector General (OIG), and audits designed to prevent future misconduct. The primary goal of the CIA is to protect federal healthcare programs and uphold integrity in the marketplace, making this choice the most relevant trigger for enforcement.

Other options such as a financial audit, a voluntary compliance report, or success in clinical trials do not inherently imply the need for remedial actions associated with legal investigations or compliance issues that necessitate the establishment of a CIA.